PERCODAN-DEMI Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Percodan-demi, and when can generic versions of Percodan-demi launch?
Percodan-demi is a drug marketed by Endo Operations and is included in one NDA.
The generic ingredient in PERCODAN-DEMI is aspirin; oxycodone hydrochloride; oxycodone terephthalate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; oxycodone hydrochloride; oxycodone terephthalate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PERCODAN-DEMI?
- What are the global sales for PERCODAN-DEMI?
- What is Average Wholesale Price for PERCODAN-DEMI?
Summary for PERCODAN-DEMI
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 2 |
| DailyMed Link: | PERCODAN-DEMI at DailyMed |
Recent Clinical Trials for PERCODAN-DEMI
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Medical College of Wisconsin | Phase 2 |
| Grünenthal GmbH | Phase 3 |
| Ortho-McNeil Janssen Scientific Affairs, LLC | Phase 3 |
US Patents and Regulatory Information for PERCODAN-DEMI
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | PERCODAN-DEMI | aspirin; oxycodone hydrochloride; oxycodone terephthalate | TABLET;ORAL | 007337-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
